Since it is widely agreed that platinum resistance often correlates with paclitaxel resistance due to the cross-resistance effect, we aimed to explore the role of CPT1A in the occurrence of paclitaxel resistance in ovarian cancer. This evidence concerns the gene CPT1A and ovarian carcinoma.